APA (7th ed.) Citation

Rodriguez-Berriguete, G., Puliyadi, R., Machado, N., Barberis, A., Prevo, R., McLaughlin, M., . . . Higgins, G. S. (2024). Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease, 15(1), 32-10. https://doi.org/10.1038/s41419-023-06405-8

Chicago Style (17th ed.) Citation

Rodriguez-Berriguete, Gonzalo, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M. Buffa, Kevin J. Harrington, and Geoff S. Higgins. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease 15, no. 1 (2024): 32-10. https://doi.org/10.1038/s41419-023-06405-8.

MLA (9th ed.) Citation

Rodriguez-Berriguete, Gonzalo, et al. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease, vol. 15, no. 1, 2024, pp. 32-10, https://doi.org/10.1038/s41419-023-06405-8.